Back to search

First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group

Kenichi Kobayashi, Akira Inoue, Makoto Maemondo, Shunichi Sugawara, Hiroshi Isobe
DOI: 10.1200/jco.2009.27.15_suppl.8016
Journal of Clinical Oncology

Data up to Jan 2025

Published2009
Citations65
References0
Fields
MedicineInternal medicineOncologyGastroenterology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus… (2009) – Journal of Clinical Oncology | Metascience Observatory Explorer